Lung Cancer

1

Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in a lung cancer screening program

Reiter, Michael J., Nemesure, Allison, Madu, Ezemonye, Reagan, Lisa, Plank, April

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 2.56 MB

english, 2018

2

Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis

Yang, Lin, Wang, Shidan, Gerber, David E., Zhou, Yunyun, Xu, Feng, Liu, Jiewei, Liang, Hao, Xiao, Guanghua, Zhou, Qinghua, Gazdar, Adi, Xie, Yang

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 566 KB

english, 2018

3

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma

Kopecka, Joanna, Salaroglio, Iris C., Righi, Luisella, Libener, Roberta, Orecchia, Sara, Grosso, Federica, Milosevic, Vladan, Ananthanarayanan, Preeta, Ricci, Luisa, Capelletto, Enrica, Pradotto, Moni

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 3.11 MB

english, 2018

4

Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III

Yanagawa, Naoki, Shiono, Satoshi, Endo, Makoto, Ogata, Shin-ya

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 2.32 MB

english, 2018

5

Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis

Verma, Vivek, Ahern, Christopher A., Berlind, Christopher G., Lindsay, William D., Grover, Surbhi, Culligan, Melissa J., Friedberg, Joseph S., Simone, Charles B.

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 618 KB

english, 2018

6

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations

Ricciuti, Biagio, Baglivo, Sara, Ludovini, Vienna, Sidoni, Angelo, Metro, Giulio, Brambilla, Marta, Siggillino, Annamaria, Reda, Maria Sole, Rebonato, Alberto, Maiettini, Daniele, Chiari, Rita

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 606 KB

english, 2018

7

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden

Tendler, Salomon, Grozman, Vitali, Lewensohn, Rolf, Tsakonas, Georgios, Viktorsson, Kristina, De Petris, Luigi

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 1.20 MB

english, 2018

8

Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy

Lee, Chia Ching, Zheng, Huili, Soon, Yu Yang, Foo, Ling Li, Koh, Wee Yao, Leong, Cheng Nang, Vellayappan, Balamurugan, Tey, Jeremy Chee Seong, Tham, Ivan Weng Keong

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 214 KB

english, 2018

9

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

Reck, Martin, Garassino, Marina Chiara, Imbimbo, Martina, Shepherd, Frances A., Socinski, Mark A., Shih, Jin-Yuan, Tsao, Anne, Lee, Pablo, Winfree, Katherine B., Sashegyi, Andreas, Cheng, Rebecca, Var

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 490 KB

english, 2018

10

Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer

Robin, Tyler P., Jones, Bernard L., Amini, Arya, Koshy, Matthew, Gaspar, Laurie E., Liu, Arthur K., Nath, Sameer K., Kavanagh, Brian D., Camidge, D. Ross, Rusthoven, Chad G.

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 298 KB

english, 2018

11

EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism

Liu, Sangtian, He, Yayi, Jiang, Tao, Ren, Shengxiang, Zhou, Fei, Zhao, Chao, Li, Xuefei, Zhang, Jie, Su, Chunxia, Chen, Xiaoxia, Cai, Weijing, Gao, Guanghui, Li, Wei, Wu, Fengying, Li, Jiayu, Zhao, Ji

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 1.32 MB

english, 2018

12

Cost-effectiveness analysis of policy options on first-line treatments for advanced, non-small cell lung cancer in Thailand

Limwattananon, Chulaporn, Limwattananon, Supon, Waleekhachonloet, Onanong, Rattanachotphanit, Thananan

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 681 KB

english, 2018

13

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Guibert, Nicolas, Delaunay, Myriam, Lusque, Amélie, Boubekeur, Nadia, Rouquette, Isabelle, Clermont, Estelle, Mourlanette, Jean, Gouin, Sandrine, Dormoy, Inge, Favre, Gilles, Mazieres, Julien, Pradine

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 812 KB

english, 2018

14

Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials

Maymani, Hossein, Hess, Kenneth, Groisberg, Roman, Hong, David S., Naing, Aung, Piha-Paul, Sarina, Janku, Filip, Fu, Siqing, Tsimberidou, Apostolia M., Pant, Shubham, Karp, Daniel, Liu, Shuang, Sun, M

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 422 KB

english, 2018

15

Lorlatinib – Induced pulmonary arterial hypertension

Chabrol, Alexandre, Mayenga, Marie, Hamid, Abdul Momen, Friard, Sylvie, Salvator, Hélène, Doubre, Hélèe, Fraboulet, Séverine, Metivier, Anne-Cécile, Catherinot, Emilie, Rivaud, Elisabeth, Chaumais, Ma

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 142 KB

english, 2018

16

Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance

Du, Meijun, Thompson, Jonathan, Fisher, Hannah, Zhang, Peng, Huang, Chiang-Ching, Wang, Liang

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 2.11 MB

english, 2018

17

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)

Muley, Thomas, Rolny, Vinzent, He, Ying, Wehnl, Birgit, Escherich, Achim, Warth, Arne, Stolp, Christa, Schneider, Marc A., Dienemann, Hendrik, Meister, Michael, Herth, Felix J., Dayyani, Farshid

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 537 KB

english, 2018

18

Editorial Board

Journal:

Lung Cancer

Year:

2018

Language:

english

File:

PDF, 87 KB

english, 2018

19

Volume 120

Frequency and distribution of incidental findings deemed appropriate for S modifier designation on low-dose CT in a lung cancer screening program

Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma

Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III

Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis

Long-term survival with erlotinib in advanced lung adenocarcinoma harboring synchronous EGFR G719S and KRAS G12C mutations

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden

Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer

EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphism

Cost-effectiveness analysis of policy options on first-line treatments for advanced, non-small cell lung cancer in Thailand

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials

Lorlatinib – Induced pulmonary arterial hypertension

Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance

The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)

Editorial Board

Contents